| Dr Maria Juvy Roque Libao, DDS | |
|
2500 Main St, Red Bluff, CA 96080-2336 | |
| (530) 529-2567 | |
| Not Available |
| Full Name | Dr Maria Juvy Roque Libao |
|---|---|
| Gender | Female |
| Speciality | Dentist - General Practice |
| Location | 2500 Main St, Red Bluff, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013185636 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 56827 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Maria Juvy Roque Libao, DDS 1924 Balzac Ct, Redding, CA 96003-9330 Ph: (530) 222-4917 | Dr Maria Juvy Roque Libao, DDS 2500 Main St, Red Bluff, CA 96080-2336 Ph: (530) 529-2567 |
News Archive
A kidney condition that can arise in children and was until recently believed to disappear after puberty may persist into adulthood and cause significant long-term complications, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The findings indicate that better treatment options are needed for children with the disorder, called minimal change nephrotic syndrome.
Spectrum Pharmaceuticals today announced that the second of two Phase 3 pivotal clinical trials of apaziquone has achieved its enrollment target. The two trials enrolled more than 1600 patients with non-muscle invasive bladder cancer. As per the collaboration agreement with Allergan, a $1.5 million milestone payment will be paid to Spectrum Pharmaceuticals.
African-American women undergo more physical "wear-and-tear" during the first year after giving birth than Latina and white women, a consequence that may have long-lasting health effects, according to a study of a diverse group of more than 2,400 low-income women.
Initial results of a study conducted at 100 centers worldwide indicate that belatacept, a first-in-class costimulation blocker can prevent the immune system rejecting new organs. The results also suggest that it may provide similar patient and graft survival to cyclosporine but with fewer side effects and superior kidney function after 12 months. The study, published today in the American Journal of Transplantation, provides the first findings to come from BENEFIT (Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial).
At the 61st Annual Meeting of the German Society for Hygiene and Microbiology on September 20-23, 2009 in Goettingen, Bruker Daltonics announces that three major German private clinical microbiology laboratories have extended their accreditation according to DIN EN ISO 15189 to include the use of Bruker's MALDI Biotyper molecular identification solution.
› Verified 5 days ago
Katrina Elizabeth Perdue, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 2150 Main St, Suite #1, Red Bluff, CA 96080 Phone: 530-527-7951 Fax: 530-527-7955 | |
Radu Alexandru Jifcu, DMD Dentist Medicare: Medicare Enrolled Practice Location: 2500 Main St, Red Bluff, CA 96080 Phone: 530-529-2567 | |
Daniel Murolo, M.S, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 2500 Main St, Red Bluff, CA 96080 Phone: 530-529-2567 | |
Dr. Enos Alan Heinzen, D.D.S Dentist Medicare: Medicare Enrolled Practice Location: 1010 Jefferson St, Red Bluff, CA 96080 Phone: 530-527-7800 | |
David Nguyen, DDS Dentist Medicare: Medicare Enrolled Practice Location: 2500 Main St, Red Bluff, CA 96080 Phone: 530-529-2567 | |
Leah Marie Stroing, DDS Dentist Medicare: Medicare Enrolled Practice Location: 2500 Main St, Red Bluff, CA 96080 Phone: 530-529-2567 |